M. Konigshoff (Denver, United States of America), B. Crestani (Paris, France)
Late Breaking Abstract - Repopulated healthy and IPF lung scaffolds show temporal differences in ECM turnover
L. Elowsson Rendin (Lund, Sweden), A. Löfdahl (Lund, Sweden), E. Åhrman (Lund, Sweden), C. Müller (Lund, Sweden), O. Rosmark (Lund, Sweden), X. Zhou (Gothenburg, Sweden), G. Dellgren (Gothenburg, Sweden), M. Silverborn (Gothenburg, Sweden), L. Bjermer (Lund, Sweden), A. Larsson-Callerfelt (Lund, Sweden), J. Malmström (Lund, Sweden), G. Westergren-Thorsson (Lund, Sweden)
|    |
LSC - 2019 - TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis
P. Boutanquoi (Dijon, France), G. Beltramo (Dijon, France), L. Dondaine (Dijon, France), P. Bellaye (Dijon, France), O. Burgy (Aurora, United States of America), B. Crestani (Paris, France), C. Garrido (Dijon, France), F. Goirand (Dijon, France), P. Bonniaud (Dijon, France)
| |
LSC - 2019 - Development of pulmonary fibrosis in conditional Nedd4-2 deficient mice
D. Leitz (Heidelberg, Germany), P. Konietzke (Heidelberg, Germany), M. Wielpütz (Heidelberg, Germany), M. Beers (Philadelphia, United States of America), M. Mall (Berlin, Germany), J. Duerr (Berlin, Germany), S. Fraumann (Heidelberg, Germany)
|  |
Role of the TGFß1-mTOR axis in fibroblast-directed alveolar epithelial regeneration in IPF
M. Platé (London, United Kingdom), R. Hynds (London, United Kingdom), H. Woodcock (London, United Kingdom), R. Chambers (London, United Kingdom)
| |
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
A. Haak (Rochester, United States of America), E. Kostallari (Rochester, United States of America), D. Sicard (Rochester, United States of America), G. Ligresti (Rochester, United States of America), K. Choi (Rochester, United States of America), N. Caporarello (Rochester, United States of America), D. Jones (Rochester, United States of America), Q. Tan (Rochester, United States of America), J. Meridew (Rochester, United States of America), A. Diaz Espinosa (Rochester, United States of America), A. Aravamudhan (Rochester, United States of America), J. Maiers (Rochester, United States of America), R. Britt (Rochester, United States of America), A. Roden (Rochester, United States of America), C. Pabelick (Rochester, United States of America), Y. Prakash (Rochester, United States of America), S. Nouraie (Pittsburgh, United States of America), X. Li (Pittsburgh, United States of America), Y. Zhang (Pittsburgh, United States of America), D. Kass (Pittsburgh, United States of America), D. Lagares (Boston, United States of America), A. Tager (Boston, United States of America), X. Varelas (Boston, United States of America), V. Shah (Rochester, United States of America), D. Tschumperlin (Rochester, United States of America)
| |
SRC family kinase inhibition reduces NOX4 expression in bronchial epithelial cells from Idiopathic Pulmonary Fibrosis patients
C. Veith (Maastricht, Netherlands), N. Kahn (Heidelberg, Germany), F. Van Schooten (Maastricht, Netherlands), A. Boots (Maastricht, Netherlands), F. Herth (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany), M. Schneider (Heidelberg, Germany), M. Meister (Heidelberg, Germany)
| |
FGF19, a potential innovative target in Idiopathic Pulmonary Fibrosis?
A. Justet (Paris , France), M. Hachem (Paris , France), T. Boghanim (Paris , France), M. Jaillet (Paris , France), L. Ling (San Francisco , United States of America), A. Mailleux (Paris , France), B. Crestani (Paris , France)
| |